These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27016630)

  • 1. Dynamic characterization of HLA-B*44 Alleles: A comparative molecular dynamics simulation study.
    Ozbek P
    Comput Biol Chem; 2016 Jun; 62():12-6. PubMed ID: 27016630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational characterization of residue couplings and micropolymorphism-induced changes in the dynamics of two differentially disease-associated human MHC class-I alleles.
    Serçinoğlu O; Ozbek P
    J Biomol Struct Dyn; 2018 Feb; 36(3):724-740. PubMed ID: 28278760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative molecular dynamics analysis of tapasin-dependent and -independent MHC class I alleles.
    Sieker F; Springer S; Zacharias M
    Protein Sci; 2007 Feb; 16(2):299-308. PubMed ID: 17242432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tapasin dependence of MHC class I molecules correlates with conformational changes upon peptide dissociation: a molecular dynamics simulation study.
    Sieker F; Straatsma TP; Springer S; Zacharias M
    Mol Immunol; 2008 Aug; 45(14):3714-22. PubMed ID: 18639935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B*44 allotypes.
    Badrinath S; Saunders P; Huyton T; Aufderbeck S; Hiller O; Blasczyk R; Bade-Doeding C
    Haematologica; 2012 Jan; 97(1):98-106. PubMed ID: 21993680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homology modelling of frequent HLA class-II alleles: A perspective to improve prediction of HLA binding peptide and understand the HLA associated disease susceptibility.
    Kashyap M; Farooq U; Jaiswal V
    Infect Genet Evol; 2016 Oct; 44():234-244. PubMed ID: 27421208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling between side chain interactions and binding pocket flexibility in HLA-B*44:02 molecules investigated by molecular dynamics simulations.
    Ostermeir K; Springer S; Zacharias M
    Mol Immunol; 2015 Feb; 63(2):312-9. PubMed ID: 25146482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of peptides presented by an HLA class I low expression allele.
    Hinrichs J; Föll D; Bade-Döding C; Huyton T; Blasczyk R; Eiz-Vesper B
    Haematologica; 2010 Aug; 95(8):1373-80. PubMed ID: 20220067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: the limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes.
    Yashiki S; Fujiyoshi T; Arima N; Osame M; Yoshinaga M; Nagata Y; Tara M; Nomura K; Utsunomiya A; Hanada S; Tajima K; Sonoda S
    AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1047-61. PubMed ID: 11485622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
    Mortier MC; Jongert E; Mettens P; Ruelle JL
    BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06.
    Eichmann M; de Ru A; van Veelen PA; Peakman M; Kronenberg-Versteeg D
    Tissue Antigens; 2014 Oct; 84(4):378-88. PubMed ID: 25154780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
    Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
    Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico analysis of peptide binding features of HLA-B*4006.
    Gadewal NS; Joshi NN
    Indian J Exp Biol; 2012 Feb; 50(2):93-100. PubMed ID: 22670471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature of recombination in HLA-B*4207.
    Eiz-Vesper B; Deluca DS; Blasczyk R; Horn PA
    Tissue Antigens; 2007 Aug; 70(2):164-8. PubMed ID: 17610423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the obstacle of incompatibility at residue 156 within HLA-B*35 subtypes.
    Manandhar T; Kunze-Schumacher H; Huyton T; Celik AA; Blasczyk R; Bade-Doeding C
    Immunogenetics; 2016 Apr; 68(4):247-60. PubMed ID: 26758079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel HLA-B35 subtypes: putative gene conversion events with donor sequences from alleles common in native Americans (HLA-B*4002 or B*4801).
    Marcos CY; Fernández-Vina MA; Lázaro AM; Nulf CJ; Raimondi EH; Stastny P
    Hum Immunol; 1997 Apr; 53(2):148-55. PubMed ID: 9129972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tapasin facilitation of natural HLA-A and -B allomorphs is strongly influenced by peptide length, depends on stability, and separates closely related allomorphs.
    Geironson L; Thuring C; Harndahl M; Rasmussen M; Buus S; Røder G; Paulsson KM
    J Immunol; 2013 Oct; 191(7):3939-47. PubMed ID: 23980206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel HLA-B allele, HLA-B*5529, by haplotype-specific sequencing.
    Emmerich F; Schönemann C; Galicki L; Salama A
    Tissue Antigens; 2008 May; 71(5):486. PubMed ID: 18346031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of peptide-HLA-I complexes and tapasin folding facilitation--tools to define immunogenic peptides.
    Geironson L; Røder G; Paulsson K
    FEBS Lett; 2012 May; 586(9):1336-43. PubMed ID: 22616994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
    Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
    Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.